FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207182762> ?p ?o ?g. }

• W3207182762 abstract "Methamphetamine/amphetamine use has sharply increased among people with opioid use disorder (OUD). It is therefore important to understand whether and how use of these substances may impact receipt of, and outcomes associated with, medications for OUD (MOUD). This systematic review identified studies that examined associations between methamphetamine/amphetamine use or use disorder and 3 classes of outcomes: (1) receipt of MOUD, (2) retention in MOUD, and (3) opioid abstinence during MOUD.We searched 3 databases (PubMed/MEDLINE, PsycINFO, CINAHL Complete) from 1/1/2000 to 7/28/2020 using key words and subject headings, and hand-searched reference lists of included articles. English-language studies of people with documented OUD/opioid use that reported a quantitative association between methamphetamine/amphetamine use or use disorder and an outcome of interest were included. Study data were extracted using a standardized template, and risk of bias was assessed for each study. Screening, inclusion, data extraction and bias assessment were conducted independently by 2 authors. Study characteristics and findings were summarized for each class of outcomes.Thirty-nine studies met inclusion criteria. Studies generally found that methamphetamine/amphetamine use or use disorder was negatively associated with receiving methadone and buprenorphine; 2 studies suggested positive associations with receiving naltrexone. Studies generally found negative associations with retention; most studies finding no association had small samples, and these studies tended to examine shorter retention timeframes and describe provision of adjunctive services to address substance use. Studies generally found negative associations with opioid abstinence during treatment among patients receiving methadone or sustained-release naltrexone implants, though observed associations may have been confounded by other polysubstance use. Most studies examining opioid abstinence during other types of MOUD treatment had small samples.Overall, existing research suggests people who use methamphetamine/amphetamines may have lower receipt of MOUD, retention in MOUD, and opioid abstinence during MOUD. Future research should examine how specific policies and treatment models impact MOUD outcomes for these patients, and seek to understand the perspectives of MOUD providers and people who use both opioids and methamphetamine/amphetamines. Efforts to improve MOUD care and overdose prevention strategies are needed for this population." @default.
• W3207182762 created "2021-10-25" @default.
• W3207182762 creator A5015721883 @default.
• W3207182762 creator A5051875554 @default.
• W3207182762 creator A5076117109 @default.
• W3207182762 creator A5083099844 @default.
• W3207182762 creator A5089202951 @default.
• W3207182762 date "2021-10-11" @default.
• W3207182762 modified "2023-10-17" @default.
• W3207182762 title "The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review" @default.
• W3207182762 cites W1516008423 @default.
• W3207182762 cites W1724694251 @default.
• W3207182762 cites W1966361923 @default.
• W3207182762 cites W1971285051 @default.
• W3207182762 cites W1981043364 @default.
• W3207182762 cites W1992194010 @default.
• W3207182762 cites W2009515465 @default.
• W3207182762 cites W2010189130 @default.
• W3207182762 cites W2013061587 @default.
• W3207182762 cites W2036022242 @default.
• W3207182762 cites W2057252503 @default.
• W3207182762 cites W2058626041 @default.
• W3207182762 cites W2063441063 @default.
• W3207182762 cites W2067989920 @default.
• W3207182762 cites W2082977560 @default.
• W3207182762 cites W2089003623 @default.
• W3207182762 cites W2114316899 @default.
• W3207182762 cites W2122814783 @default.
• W3207182762 cites W2123708623 @default.
• W3207182762 cites W2131683695 @default.
• W3207182762 cites W2139852527 @default.
• W3207182762 cites W2143015721 @default.
• W3207182762 cites W2143507618 @default.
• W3207182762 cites W2149717129 @default.
• W3207182762 cites W2150131207 @default.
• W3207182762 cites W2158292788 @default.
• W3207182762 cites W2164375280 @default.
• W3207182762 cites W2167194672 @default.
• W3207182762 cites W2184554481 @default.
• W3207182762 cites W2331803526 @default.
• W3207182762 cites W2333643931 @default.
• W3207182762 cites W2519350321 @default.
• W3207182762 cites W2529099983 @default.
• W3207182762 cites W2558734034 @default.
• W3207182762 cites W2610572186 @default.
• W3207182762 cites W2612662751 @default.
• W3207182762 cites W2614231909 @default.
• W3207182762 cites W2729232923 @default.
• W3207182762 cites W2740332189 @default.
• W3207182762 cites W2756105348 @default.
• W3207182762 cites W2783607606 @default.
• W3207182762 cites W2790165261 @default.
• W3207182762 cites W2801711697 @default.
• W3207182762 cites W2804188740 @default.
• W3207182762 cites W2806076702 @default.
• W3207182762 cites W2888745901 @default.
• W3207182762 cites W2897850254 @default.
• W3207182762 cites W2899112555 @default.
• W3207182762 cites W2902748282 @default.
• W3207182762 cites W2920919694 @default.
• W3207182762 cites W2942776977 @default.
• W3207182762 cites W2942863111 @default.
• W3207182762 cites W2960150308 @default.
• W3207182762 cites W2962839503 @default.
• W3207182762 cites W2967272494 @default.
• W3207182762 cites W2968428547 @default.
• W3207182762 cites W2973129289 @default.
• W3207182762 cites W2975156658 @default.
• W3207182762 cites W2976392433 @default.
• W3207182762 cites W2990459606 @default.
• W3207182762 cites W2995283047 @default.
• W3207182762 cites W2996755245 @default.
• W3207182762 cites W3005454586 @default.
• W3207182762 cites W3008253059 @default.
• W3207182762 cites W3012836820 @default.
• W3207182762 cites W3027676659 @default.
• W3207182762 cites W3040801838 @default.
• W3207182762 cites W3044677262 @default.
• W3207182762 cites W3083946771 @default.
• W3207182762 cites W3087096407 @default.
• W3207182762 cites W3087409603 @default.
• W3207182762 cites W3109991036 @default.
• W3207182762 cites W3118735640 @default.
• W3207182762 cites W3127038227 @default.
• W3207182762 cites W3127222350 @default.
• W3207182762 cites W3188878117 @default.
• W3207182762 cites W4294215472 @default.
• W3207182762 doi "https://doi.org/10.1186/s13722-021-00266-2" @default.
• W3207182762 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8504567" @default.
• W3207182762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34635170" @default.
• W3207182762 hasPublicationYear "2021" @default.
• W3207182762 type Work @default.
• W3207182762 sameAs 3207182762 @default.
• W3207182762 citedByCount "26" @default.
• W3207182762 countsByYear W32071827622021 @default.
• W3207182762 countsByYear W32071827622022 @default.
• W3207182762 countsByYear W32071827622023 @default.
• W3207182762 crossrefType "journal-article" @default.
• W3207182762 hasAuthorship W3207182762A5015721883 @default.
• W3207182762 hasAuthorship W3207182762A5051875554 @default.

• next